Stay updated on Melanoma Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.

Latest updates to the Melanoma Immunotherapy Clinical Trial page
- Check4 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025. Additionally, the revision number has been updated from v2.16.3 to v2.16.4.SummaryDifference0.7%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.0%
- Check19 days agoChange DetectedThe page has been updated to include a new version of a medical study citation, indicating a revision from v2.16.1 to v2.16.2.SummaryDifference0.2%
- Check26 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference0.6%
- Check33 days agoChange DetectedThe page has been updated to reflect new definitions and assessments related to progression-free survival (PFS) and overall survival (OS), including changes in the time frames for these measures and the methodology for assessing health-related quality of life (HRQoL). Additionally, specific dates and version revisions have been added.SummaryDifference29%
- Check40 days agoChange DetectedThe page has removed a citation regarding the overall survival with combined Nivolumab and Ipilimumab in advanced melanoma, which may affect the credibility and informational content of the page.SummaryDifference0.2%
Stay in the know with updates to Melanoma Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.